osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

N Bucay1, I Sarosi, C R Dunstan

  • 1Department of Molecular Genetics, Amgen, Inc., Thousand Oaks, California 91320-1789, USA.

Genes & Development
|June 6, 1998
PubMed

Insights

Osteoprotegerin (OPG) is vital for maintaining bone density and preventing fractures. OPG deficiency in mice led to bone loss and unexpected vascular calcification, linking bone health and cardiovascular disease.

Area of Science:

  • Biochemistry
  • Physiology
  • Genetics

Background:

  • Osteoprotegerin (OPG) is a key secreted protein that regulates osteoclast formation.
  • Osteoclast activity is critical for bone remodeling and maintaining bone mass.

Purpose of the Study:

  • To investigate the physiological role of OPG in postnatal bone metabolism.
  • To determine the effects of OPG deficiency on bone density and structure.
  • To explore potential links between OPG, bone health, and vascular calcification.

Main Methods:

  • Generation of OPG-deficient (OPG-/-) mice.
  • Assessment of bone density, structure, and porosity in adolescent and adult OPG-/- mice.
  • Histological examination of bone and vascular tissues.

Main Results:

  • OPG-/- mice exhibited significantly decreased total bone density.
  • Severe trabecular and cortical bone porosity, skull bone thinning, and increased fracture incidence were observed.
  • Unexpectedly, OPG-/- mice displayed medial calcification of the aorta and renal arteries.

Conclusions:

  • OPG is a critical regulator of postnatal bone mass.
  • OPG deficiency leads to severe osteoporosis-like phenotypes.
  • The findings suggest a potential role for OPG in the association between osteoporosis and vascular calcification.

Related Concept Videos

Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...